Solid Biosciences Inc. (SLDB)
$9.77-$0.36 (-3.55%) Today
Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 9 | 697,500 | |
| Option exercise | 2 | 6,880 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
69 Form 4 filings on record, the earliest from Oct 4, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Ian F. Smith | Option exercise | Common Stock | 4,574 | - | - | |
| Ian F. Smith | Option exercise | Restricted Stock Units | 4,574 | $0.00 | - | |
| David T. Howton - Officer | Option exercise | Common Stock | 13,051 | - | - | |
| David T. Howton - Officer | Open-market sale | Common Stock | 5,072 | $5.60 | $28K | |
| David T. Howton - Officer | Option exercise | Restricted Stock Units | 13,051 | $0.00 | - | |
| Alexander Cumbo - Officer | Option exercise | Common Stock | 28,612 | - | - | |
| Alexander Cumbo - Officer | Open-market sale | Common Stock | 11,114 | $5.60 | $62K | |
| Alexander Cumbo - Officer | Option exercise | Restricted Stock Units | 28,612 | $0.00 | - | |
| Paul Herzich - Officer | Option exercise | Common Stock | 7,239 | - | - | |
| Paul Herzich - Officer | Open-market sale | Common Stock | 2,777 | $5.60 | $16K | |
| Paul Herzich - Officer | Option exercise | Restricted Stock Units | 7,239 | $0.00 | - | |
| Jessie Hanrahan - Officer | Option exercise | Common Stock | 11,862 | - | - | |
| Jessie Hanrahan - Officer | Open-market sale | Common Stock | 4,610 | $5.60 | $26K | |
| Jessie Hanrahan - Officer | Option exercise | Restricted Stock Units | 11,862 | $0.00 | - | |
| Adam Leo Stone - Director | Grant or award | Director Stock Option (Right to Buy) | 34,400 | $0.00 | - | |
| PERCEPTIVE ADVISORS LLC - Director | Grant or award | Director Stock Option (Right to Buy) | 34,400 | $0.00 | - | |
| Gabriel Brooks - Officer | Option exercise | Common Stock | 9,750 | - | - | |
| Gabriel Brooks - Officer | Open-market sale | Common Stock | 2,923 | $6.50 | $19K | |
| Gabriel Brooks - Officer | Option exercise | Restricted Stock Units | 9,750 | $0.00 | - | |
| Ian F. Smith | Option exercise | Common Stock | 3,255 | - | - | |
| Ian F. Smith | Option exercise | Restricted Stock Units | 3,255 | $0.00 | - |
This is as far as the anonymous view goes. Create a free account for all 69 SLDB filings on record.
Solid Biosciences Inc. (SLDB) had 10 insider filings in the last 90 days, with the most recent on 2026-07-07. The full record for SLDB runs to 69 Form 4 filings, the earliest from 2024-10-04. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of SLDB were filed in the last 90 days.
No insider sales of SLDB were filed in the last 90 days. 34 sales are on record for this company.
This page tracks SLDB Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add SLDB to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
